Actelion Pharmaceuticals

Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs. They have been present in the Dutch market since 2002 where they market and distribute all of their products.

The company is focused on the discovery, development, and commercialization of synthetic, small-molecule drugs as innovative treatments to serve high unmet medical needs.

Actelion combines the innovation, entrepreneurial spirit, and flexibility of biotech with the financial, risk management, regulatory, and commercial discipline of a large pharmaceutical company. It has the proven ability to discover new compounds and to rapidly move compounds from research through development to commercialization
Type: NORMAL
Address: Actelion Pharmaceuticals Nederland B.V / Beneluxlaan 2B / 3446 GR Woerden / The Netherlands 3446 GR Woerden
Website: www.actelion.nl
Phone: +31 348 435 950
Fax: +31 348 420 904
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.